Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01910610
Title Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer (STRATEGIC-1)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Cetuximab

Irinotecan + Panitumumab

Panitumumab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Bevacizumab + Capecitabine + Oxaliplatin

Cetuximab + Irinotecan

Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST